Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Alzheimer's Disease Burden in China (ABC) Study: a Nationwide Multicentre Cross-sectional and Prospective Cohort Study
Authors not listed
Xuanwu Hospital, Beijing · 2023
Abstract
Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Anonymous. (2023). The Alzheimer's Disease Burden in China (ABC) Study: a Nationwide Multicentre Cross-sectional and Prospective Cohort Study. <em>Xuanwu Hospital, Beijing</em>. https://clinicaltrials.gov/study/NCT05995418
Vancouver
Anonymous. The Alzheimer's Disease Burden in China (ABC) Study: a Nationwide Multicentre Cross-sectional and Prospective Cohort Study. Xuanwu Hospital, Beijing. 2023.
BibTeX
@misc{anon2023TheAlz,
title = {The Alzheimer's Disease Burden in China (ABC) Study: a Nationwide Multicentre Cross-sectional and Prospective Cohort Study},
author = {Anonymous},
journal = {Xuanwu Hospital, Beijing},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Beijing Friendship Hospital 2015
Open access · US-GOV
Monetary Cost of Alzheimer's Disease in China: Study Protocol for a Cluster Randomized Observational Study
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Life Sciences 1994
Citation only
Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity
Seoul National University Hospital 2014
Open access · US-GOV